Aeterna Zentaris Inc.
NASDAQ:AEZS 3:30:47 PM EDT
| Market Cap (Intraday) | 17.94M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.79 |
| 50-Day MA | $3.83 |
| 200-Day MA | $5.56 |
Aeterna Zentaris Inc. Stock, NASDAQ:AEZS
222 Bay Street, Suite 3000, Toronto, Ontario M5K 1E7
Phone: +1 418 652-8525
Number of Employees: 17
Description
�†terna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.